Cancer research: does it deliver for the patient?

Growth of tumor-derived activated T cells for the treatment of advanced cancer.

Cancer biotherapy & radiopharmaceuticals·2000

A revolution in the treatment of non-Hodgkin's lymphoma.

Cancer biotherapy & radiopharmaceuticals·2000

A phase I and pharmacokinetic study of CBT-1 as a multidrug resistance modulator in the treatment of patients with advanced cancer.

Cancer biotherapy & radiopharmaceuticals·2000

Phase I study of CBT-1 and Taxol in patients with Taxol resistant cancers.

Cancer biotherapy & radiopharmaceuticals·2000

Chemo-biotherapy with 5-fluorouracil, leucovorin, and alpha interferon in metastatic carcinoma of the colon--a Cancer Biotherapy Research Group [CBRG] phase II study.

Cancer biotherapy & radiopharmaceuticals·2000

The Cancer Biotherapy Research Group [CBRG], formerly the National Biotherapy Study Group [NBSG]: a 10-year perspective.

Cancer biotherapy & radiopharmaceuticals·1997

In vitro and in vivo production of interleukin-6 induced by muramyl peptides and lipopolysaccharide in normal dogs.

Cancer biotherapy·1995

Reovirus type 3 chemoimmunotherapy of murine lymphoma is abrogated by cyclosporine.

Cancer biotherapy·1995

Allogeneic human liposomal melanoma vaccine with or without IL-2 in metastatic melanoma patients: clinical and immunobiological effects.

Cancer biotherapy·1995

In vivo distribution of integrins in renal cell carcinoma: integrin-phenotype alteration in different degrees of tumor differentiation and VLA-2 involvement in tumor metastasis.

Cancer biotherapy·1995

Human, recombinant interleukin-2 induces in vitro histamine release in a dose-dependent manner.

Cancer biotherapy·1995

Treatment of refractory low grade lymphoma with chlorambucil alternating with interferon and radiotherapy.

Cancer biotherapy·1995

Decades of intensive care medicine trials: what randomised evidence has changed, corrected, and still questions to resolve.

Intensive care medicine·2026

Pilot Study of Oral Microbiome and Psychoneurological Symptom Cluster in Breast Cancer.

Nursing research·2026

Dietary Terpenoids in Advancing Biofilm-Mediated Cancer Prevention: Antibiofilm Cascade, Molecular Crosstalk, and Nano-Facilitated Functional Delivery.

Cell biochemistry and function·2026

Primary small-cell neuroendocrine carcinoma of the bladder: a very rare histological subtype.

Oxford medical case reports·2026

The role of non-coding RNAs in regulating R-loop dynamics in cancer: Mechanisms and therapeutic implications.

Acta pharmaceutica Sinica. B·2026

Iron homeostasis and macrophage polarization in oral squamous cell carcinoma: mechanisms and therapeutic perspectives.

Frontiers in immunology·2026

Related Experiment Videos

Cancer research: does it deliver for the patient?

Related Concept Videos

Growth of tumor-derived activated T cells for the treatment of advanced cancer.

A revolution in the treatment of non-Hodgkin's lymphoma.

A phase I and pharmacokinetic study of CBT-1 as a multidrug resistance modulator in the treatment of patients with advanced cancer.

Phase I study of CBT-1 and Taxol in patients with Taxol resistant cancers.

Chemo-biotherapy with 5-fluorouracil, leucovorin, and alpha interferon in metastatic carcinoma of the colon--a Cancer Biotherapy Research Group [CBRG] phase II study.

The Cancer Biotherapy Research Group [CBRG], formerly the National Biotherapy Study Group [NBSG]: a 10-year perspective.

In vitro and in vivo production of interleukin-6 induced by muramyl peptides and lipopolysaccharide in normal dogs.

Reovirus type 3 chemoimmunotherapy of murine lymphoma is abrogated by cyclosporine.

Allogeneic human liposomal melanoma vaccine with or without IL-2 in metastatic melanoma patients: clinical and immunobiological effects.

In vivo distribution of integrins in renal cell carcinoma: integrin-phenotype alteration in different degrees of tumor differentiation and VLA-2 involvement in tumor metastasis.

Human, recombinant interleukin-2 induces in vitro histamine release in a dose-dependent manner.

Treatment of refractory low grade lymphoma with chlorambucil alternating with interferon and radiotherapy.

Decades of intensive care medicine trials: what randomised evidence has changed, corrected, and still questions to resolve.

Pilot Study of Oral Microbiome and Psychoneurological Symptom Cluster in Breast Cancer.

Dietary Terpenoids in Advancing Biofilm-Mediated Cancer Prevention: Antibiofilm Cascade, Molecular Crosstalk, and Nano-Facilitated Functional Delivery.

Primary small-cell neuroendocrine carcinoma of the bladder: a very rare histological subtype.

The role of non-coding RNAs in regulating R-loop dynamics in cancer: Mechanisms and therapeutic implications.

Iron homeostasis and macrophage polarization in oral squamous cell carcinoma: mechanisms and therapeutic perspectives.

Related Experiment Videos

Cancer research: does it deliver for the patient?

Related Concept Videos

Related Articles